Clinical Trial Update: Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update (RIBS VI) evaluating bioresorbable vascular scaffolds for coronary in-stent restenosis, with the study status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary In-stent Restenosis

Snippet

Sponsor: Spanish Society of Cardiology | Conditions: Coronary In-stent Restenosis | Phase 4 | Status: UNKNOWN